Neuronal DNA damage response‐associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of A lzheimer‐type pathology
Year: 2015
Type: article
Abstract: AIMS: Oxidative damage and an associated DNA damage response (DDR) are evident in mild cognitive impairment and early Alzheimer's disease, suggesting that neuronal dysfunction resulting from oxidative DNA damage may account for some of the cognitive impairment not fully explained by Alzheimer-type pathology. METHODS: Frontal cortex (Braak stage 0-II) was obtained from the Medical Research Council's Cognitive Function and Ageing Study cohort. Neurones were isolated from eight cases (four high and four low DDR) by laser capture microdissection and changes in the transcriptome identified by microarray analysis. RESULTS: Two thousand three hundred seventy-eight genes were significantly differentially expressed (1690 up-regulated, 688 down-regulated, P < 0.001) in cases with a high neuronal DDR. Functional grouping identified dysregulation of cholesterol biosynthesis, insulin and Wnt signalling, and up-regulation of glycogen synthase kinase 3β. Candidate genes were validated by quantitative real-time polymerase chain reaction. Cerebrospinal fluid levels of 24(S)-hydroxycholesterol associated with neuronal DDR across all Braak stages (rs = 0.30, P = 0.03). CONCLUSIONS: A persistent neuronal DDR may result in increased cholesterol biosynthesis, impaired insulin and Wnt signalling, and increased GSK3β, thereby contributing to neuronal dysfunction independent of Alzheimer-type pathology in the ageing brain.
DOI: 10.1111/nan.12252
Authors: Julie E. Simpson, Paul G. Ince, Thais Minett, Fiona E. Matthews, Paul R. Heath, Pamela J. Shaw, Emily Goodall, Claire J. Garwood, Laura E. Ratcliffe, Carol Brayne, Magnus Rattray, Stephen B. Wharton, the MRC Cognitive Function and Ageing Neuropathology Study Group
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: DNA damage response, Alzheimer's disease, mild cognitive impairment, oxidative DNA damage, cholesterol biosynthesis, insulin signaling, Wnt signaling, glycogen synthase kinase-3β, 24S-hydroxycholesterol, neuronal transcriptome, Braak stages, frontal cortex, cerebrospinal fluid biomarkers, neuronal dysfunction, brain aging
Open Access status: hybrid
Estimated APC paid: $4,480
Funders: Nottingham University Hospitals NHS Trust, Alzheimer's Research Trust, National Institute for Health and Care Research, University of Nottingham, University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council, NIHR Cambridge Biomedical Research Centre
Awards: MRC Brain Banks: Joint Application to Underpin Neuroscience Research, G2637832891, Role of microRNAs in ageing at the blood-brain barrier: integrated studies in human and mouse models, MRC Brain Banks: Joint application to underpin neuroscience research, G4604477821, G4982333556, Oxidative DNA Damage and Transcriptional Impairment in Brain Ageing as an Early Contributor to Cognitive Impairment, G5751319291, NIHR Senior Investigator Award, NIHR Senior Investigator Award, G8376115369
OpenAlex ID: W1575040108
